Non-invasive in vivo assessment of IDH1 mutational status in glioma
Nature Communications2013Vol. 4(1), pp. 2429–2429
Citations Over TimeTop 10% of 2013 papers
Myriam M. Chaumeil, Peder E. Z. Larson, Hikari A. I. Yoshihara, Olivia M. Danforth, Daniel B. Vigneron, Sarah J. Nelson, Russell O. Pieper, Joanna J. Phillips, Sabrina M. Ronen
Related Papers
- → Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia(2014)31 cited
- → Isocitrate dehydrogenase 1: what it means to the neurosurgeon(2013)22 cited
- → Inhibition of mutant IDH1 in acute myeloid leukaemia(2014)9 cited
- → New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status(2011)7 cited
- Isocitrate dehydrogenase 1 mutations and human gliomas(2011)